Herborium Group, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HBRM research report →
About the company
Herborium Group, Inc. operates as a specialized firm in botanical therapeutics, focusing on the creation, licensing, and commercialization of its unique, plant-based medicinal goods for both general consumers and healthcare professionals. Its product range includes dermatological solutions like AcnEase, an herbal treatment designed to alleviate symptoms associated with hormonal acne and various forms of Rosacea.
- CEO
- Agnes Olszewski
- IPO
- 1998
- Employees
- 2
- HQ
- Fort Lee, NJ, US
Price Chart
- Market Cap
- $1.09M
- P/E
- -4.90
- P/S
- 1.32
- P/B
- -0.25
- EV/EBITDA
- -7.63
- Div Yield
- 0.00%
- Gross Margin
- 61.12%
- Op Margin
- -34.13%
- Net Margin
- -26.93%
- ROE
- 5.80%
- ROIC
- 9.74%
- Revenue
- $788.25K · -25.00%
- Net Income
- $-154,770 · 52.92%
- EPS
- $0.00 · 0.00%
- Op Income
- $-238,000
- FCF YoY
- 0.00%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 8.81
- Avg Volume
- 219.36K
Get TickerSpark's AI analysis on HBRM
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our HBRM coverage
Recent articles, reports, and earnings notes.
No research on HBRM yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate HBRM report →Similar companies
Peers in the same neighborhood.